Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
16,048,764
-
Share change
-
+1,106,621
-
Total reported value
-
$101,424,546
-
Price per share
-
$6.32
-
Number of holders
-
64
-
Value change
-
+$7,283,101
-
Number of buys
-
37
-
Number of sells
-
24
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2024
As of 31 Dec 2024,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,048,764 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Sonic GP LLC, Solas Capital Management, LLC, Rosalind Advisors, Inc., BlackRock, Inc., DG Capital Management, LLC, VANGUARD GROUP INC, HARBERT FUND ADVISORS, INC., MORGAN STANLEY, and STATE STREET CORP.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.